Charles River Laboratories Interna
$290.19Change from previous close: +1.17%Absolute change: +$3.36
At a glance
- Revenue growth
- −0.85%
- 2025 vs 2024
- Net margin
- -3.6%
- 2024: 0.3%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 7,135 | 7,528 | 8,195 | 7,603 | — |
| Current assets | 1,447 | 1,403 | 1,609 | 1,439 | — |
| Cash and equivalents | 214 | 195 | 277 | 234 | — |
| Short-term investments | — | — | — | — | 1.1 |
| Receivables | 709 | 721 | 780 | 752 | — |
| Inventory | 299 | 279 | 380 | 256 | — |
| Net property, plant and equipment | 2,017 | 2,017 | 2,034 | 1,857 | — |
| Goodwill | 2,764 | 2,847 | 3,095 | 2,850 | — |
| Other intangible assets | 340 | 723 | 864 | 955 | — |
| Long-term investments | 207 | 218 | 244 | 312 | — |
| Current liabilities | 1,120 | 994 | 1,055 | 1,092 | — |
| Accounts payable | 149 | 140 | 169 | 206 | — |
| Long-term debt | 2,112 | 2,215 | 2,647 | 2,708 | — |
| Total debt | 2,570 | 2,724 | 3,066 | 3,097 | — |
| Total liabilities | 3,924 | 4,020 | 4,536 | 4,579 | — |
| Total equity (incl. minority) | 3,211 | 3,508 | 3,659 | 3,024 | — |
| Retained earnings | 1,389 | 1,812 | 1,887 | 1,433 | — |
| Minority interest | 46.6 | 46.6 | 62.1 | 47.2 | — |